Cargando…
Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
Autores principales: | Ikeda, Hiroaki, Ueno, Hiroaki, Kawamura, Ayumi, Imai, Naoko, Okamoto, Sachiko, Mineno, Junichi, Takesako, Kazutoh, Shiku, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288585/ http://dx.doi.org/10.1186/2051-1426-2-S3-P20 |
Ejemplares similares
-
In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013) -
T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease
por: Okada, Satomi, et al.
Publicado: (2023) -
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
por: Okamoto, Sachiko, et al.
Publicado: (2012) -
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016) -
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
por: Shiku, H, et al.
Publicado: (2014)